Abstract
Mycobacterium nebraskense is a scotochromogenic mycobacterium first isolated from sputum samples of five patients at the University of Nebraska Medical Center. M. nebraskense was first identified as a pathogen in an immunocompetent host, also in Nebraska. In this case report, we describe a patient with nodular pulmonary disease most likely due to M. nebraskense, who was successfully treated with rifampin and azithromycin, representing the first case in which this organism was a pathogen outside of Nebraska and the first description of successful treatment of this infection.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Antibiotics, Antitubercular / therapeutic use
-
Azithromycin / therapeutic use
-
Connecticut
-
Diagnosis, Differential
-
Humans
-
Male
-
Middle Aged
-
Mycobacterium Infections, Nontuberculous / diagnosis*
-
Mycobacterium Infections, Nontuberculous / drug therapy
-
Mycobacterium Infections, Nontuberculous / microbiology*
-
Nontuberculous Mycobacteria / isolation & purification*
-
Rifampin / therapeutic use
-
Sputum / microbiology
-
Stents
-
Tomography, X-Ray Computed
Substances
-
Anti-Bacterial Agents
-
Antibiotics, Antitubercular
-
Azithromycin
-
Rifampin